PAVmed Inc.
PAVM- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001624326
No open-market purchases or sales by PAVmed Inc. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $5.56M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in PAVmed Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- −2 vs. Q4 2023
- Shares held
- 952.8K
- +199.1K (+26.4%) vs. Q4 2023
- Total value
- $2.03M
- −$1.07M (−34.5%) vs. Q4 2023
- New holders
- 3
- 4 more added
- Sold out
- 5
- 11 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PAVM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 19 | $5.56M |
| Q1 2026 | 21 | $5.26M |
| Q4 2025 | 32 | $468.8K |
| Q3 2025 | 36 | $677.4K |
| Q2 2025 | 32 | $755.8K |
| Q1 2025 | 31 | $873.5K |
| Q4 2024 | 26 | $653.8K |
| Q3 2024 | 22 | $1.38M |
| Q2 2024 | 26 | $931.9K |
| Q1 2024 | 24 | $2.03M |
| Q4 2023 | 26 | $3.10M |
| Q3 2023 | 65 | $3.67M |
| Q2 2023 | 58 | $3.78M |
| Q1 2023 | 61 | $3.76M |
| Q4 2022 | 64 | $4.62M |
| Q3 2022 | 73 | $10.9M |
| Q2 2022 | 76 | $11.5M |
| Q1 2022 | 96 | $27.0M |
| Q4 2021 | 108 | $65.5M |
| Q3 2021 | 109 | $198.9M |
| Q2 2021 | 101 | $134.7M |
| Q1 2021 | 92 | $80.8M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding PAVmed Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Simplex Trading, LLC | 400 | $0 | 0.00% | −591−59.6% | Reduced |
| Royal Bank of Canada | 11 | $0 | 0.00% | −27−71.1% | Reduced |
| Steward Partners Investment Advisory, LLC | 1 | $2 | 0.00% | 00.0% | Unchanged |
| Thompson Investment Management, Inc. | 4 | $9 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 7 | $15 | 0.00% | −8−53.3% | Reduced |
| JPMorgan Chase & Co | 36 | $78 | 0.00% | +6+20.0% | Added |
| M&R Capital Management Inc | 67 | $143 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 128 | $273 | 0.00% | −54−29.7% | Reduced |
| Newbridge Financial Services Group, Inc. | 134 | $287 | 0.00% | +134 | New |
| Allworth Financial LP | 420 | $899 | 0.00% | −604−59.0% | Reduced |
| CIBC Private Wealth Group, LLC | 836 | $1.71K | 0.00% | +836 | New |
| Tower Research Capital LLC (TRC) | 2,457 | $5.26K | 0.00% | −1,315−34.9% | Reduced |
| Clear Street Markets LLC | 3,612 | $8.00K | 0.00% | +3,612 | New |
| CWM, LLC | 4,672 | $10.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 5,129 | $11.0K | 0.00% | +2,545+98.5% | Added |
| Wells Fargo & Company | 7,144 | $15.3K | 0.00% | −4,274−37.4% | Reduced |
| XML Financial, LLC | 10,067 | $21.5K | 0.00% | −267−2.6% | Reduced |
| Northern Trust Corp | 11,752 | $25.1K | 0.00% | −1,205−9.3% | Reduced |
| Valeo Financial Advisors, LLC | 21,129 | $39.1K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 20,981 | $44.9K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 63,360 | $135.6K | 0.00% | +8,282+15.0% | Added |
| BlackRock Inc. | 74,912 | $160.3K | 0.00% | −100.0% | Reduced |
| Vanguard Group Inc | 300,541 | $643.2K | 0.00% | −2,065−0.7% | Reduced |
| First Manhattan Co | 425,000 | $909.5K | 0.00% | +225,000+112.5% | Added |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −22,561−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −6,017−100.0% | Sold out |
| Glassman Wealth Services | 0 | $0 | 0.00% | −2,319−100.0% | Sold out |
| Rockbridge Investment Management, LCC | 0 | $0 | 0.00% | −27−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |